High-Throughput Screening Industry Size

The report "High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025" The global high-throughput screening (HTS) market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.

Browse 432 market data Tables and 40 Figures spread through 319 Pages and in-depth TOC on "High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

The growth in this market is primarily attributed to the adoption of open, innovative models in pharmaceutical and biotechnology companies. In recent years, the pharmaceutical & biotechnology industries have adopted open innovation approaches for collaborating on drug discovery processes with academic & research institutions. In the open innovation approach, academic organizations carry out target identification and validation research, while pharmaceutical companies conduct HTS assay development and specialized screening campaigns.

The consumables segment accounted for the largest share of the product & services segment in the high-throughput screening market in 2019.

On the basis type of product & service, the high-throughput screening market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening market. The large share of this segment is mainly attributed to the consistent usage & frequent purchase of consumables, unlike instruments that are one-time purchases. Other growth drivers include the large numbers of reagents & assay kits used in HTS techniques, increasing pharmaceutical R&D spending, the rising number of promising drug candidates in the pipeline, and increasing government funding for life science research.

The drug discovery segment accounted for the largest share of the application segment in the high-throughput screening market in 2019.

Based on application, the high-throughput screening market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2019. Target identification and validation is the initial step in the drug discovery process. High-throughput screening is the most widely used technology in target identification for drug discovery programs as it helps reduce time and increase cost-efficiency. This increase in government funding for the development of new drugs will also support the growth of the drug discovery segment.

The Asia Pacific region is the fastest-growing region of the high-throughput screening market.

Asia Pacific region accounted for the fastest-growing region of the high-throughput screening market. China has emerged as the key revenue contributor to the Asia Pacific high-throughput screening market. Factors such as Chinese government policies to increase pharmaceutical innovation, growth of the pharma sector of the country, faster approval of drugs, and the growing market of CROs support market growth for HTS.

Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US),  Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).

Don’t miss out on business opportunities in High-Throughput Screening (HTS) Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]